Mark Lackner - Insider Trading & Ownership

Entity
Individual
Location
C/O Ideaya Biosciences, Inc., 7000 Shoreline Court, Suite 350, South San Francisco, CA
Summary
The estimated net worth of Mark Lackner is at least $878K dollars as of February 5, 2025. Mark Lackner is the Chief Scientific Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $878K.
All Insider Reports
All Insider Reports

Ownership of Mark Lackner

Insider Transactions Reported by Mark Lackner:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.